We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$331M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,006
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$247M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$183M |
| 3 |
WCC
WESCO International
WCC
|
+$178M |
| 4 |
Gilead Sciences
GILD
|
+$154M |
| 5 |
Delta Air Lines
DAL
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$221M |
| 2 |
3M
MMM
|
+$157M |
| 3 |
MRSH
Marsh
MRSH
|
+$120M |
| 4 |
Johnson & Johnson
JNJ
|
+$106M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Analog Devices
ADI
$185B
| $86.9M | 0.15% |
409,237
-13,500
| -3% | -$2.98M |
|
|
CNTA
127
DELISTED
Centessa Pharmaceuticals
CNTA
| $85.7M | 0.15% |
5,119,027
+924,027
| +22% | +$15.3M |
|
128
Colgate-Palmolive
CL
$73.8B
| $85.7M | 0.15% |
942,870
+377,900
| +67% | +$36.1M |
|
|
DFS
129
DELISTED
Discover Financial Services
DFS
| $85.6M | 0.15% |
494,284
+9,390
| +2% | +$1.54M |
|
130
United Parcel Service
UPS
$92.7B
| $85M | 0.15% |
673,800
-16,700
| -2% | -$2.2M |
|
131
Vulcan Materials
VMC
$36.9B
| $84.5M | 0.15% |
328,398
+167,200
| +104% | +$45M |
|
132
Vertex Pharmaceuticals
VRTX
$121B
| $84.3M | 0.15% |
209,239
-137,116
| -40% | -$63.6M |
|
|
SPR
133
DELISTED
Spirit AeroSystems
SPR
| $83.1M | 0.15% |
2,438,791
+1,029,989
| +73% | +$33.3M |
|
134
Ingersoll Rand
IR
$34.7B
| $83.1M | 0.15% |
918,311
-788,336
| -46% | -$78.5M |
|
135
Altria Group
MO
$114B
| $82.8M | 0.14% |
1,583,432
-24,900
| -2% | -$1.33M |
|
136
United Airlines
UAL
$43B
| $82.8M | 0.14% |
852,412
+542,403
| +175% | +$45.9M |
|
137
General Dynamics
GD
$104B
| $82.4M | 0.14% |
312,768
+234,435
| +299% | +$67.5M |
|
138
Prologis
PLD
$130B
| $82.4M | 0.14% |
779,100
+63,200
| +9% | +$7.26M |
|
139
Welltower
WELL
$167B
| $81M | 0.14% |
642,706
-87,800
| -12% | -$11.5M |
|
140
Honeywell
HON
$78.9B
| $80.7M | 0.14% |
378,866
-65,998
| -15% | -$13.8M |
|
|
RNAM
141
DELISTED
Avidity Biosciences
RNAM
| $80M | 0.14% |
2,751,944
-327,430
| -11% | -$13.7M |
|
142
West Pharmaceutical
WST
$24.5B
| $79.5M | 0.14% |
242,707
+64,300
| +36% | +$20.2M |
|
143
Amgen
AMGN
$210B
| $79.4M | 0.14% |
304,727
-296,935
| -49% | -$88.1M |
|
144
Intercontinental Exchange
ICE
$83.8B
| $78.4M | 0.14% |
526,459
-14,700
| -3% | -$2.33M |
|
|
MRSH
145
Marsh
MRSH
$91.4B
| $78.4M | 0.14% |
369,161
-539,400
| -59% | -$120M |
|
146
Northrop Grumman
NOC
$78.4B
| $77.5M | 0.14% |
165,082
+45,458
| +38% | +$22.9M |
|
147
MetLife
MET
$61.9B
| $77.2M | 0.14% |
943,426
-61,100
| -6% | -$5.08M |
|
148
Geron
GERN
$860M
| $77.2M | 0.13% |
21,800,000
-7,075,000
| -25% | -$28.3M |
|
149
Cadence Design Systems
CDNS
$93.8B
| $77M | 0.13% |
256,400
-1,700
| -0.7% | -$494K |
|
150
Intel
INTC
$509B
| $76.8M | 0.13% |
3,829,685
+7,600
| +0.2% | +$171K |
|
Similar funds
Adage Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Adage Capital Partners held 1,006 positions worth $57.2B, up 0.97% from $56.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Adage Capital Partners's Q4 2024 filing shows 143 new, 295 increased, 385 reduced and 137 closed positions. Its largest new stake was Gilead Sciences: 1,714,130 shares worth $158M. The largest sale was Marathon Oil Corporation, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2024 buy was Gilead Sciences: 1,714,130 shares worth $158M.
- Adage Capital Partners added most to ConocoPhillips in Q4 2024, an estimated $247M increase.
- Adage Capital Partners's biggest Q4 2024 reduction was 3M, cutting an estimated $157M.
- Adage Capital Partners fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $221M.
- Adage Capital Partners's ten largest holdings make up 32% of its $57.2B portfolio in Q4 2024.
- Adage Capital Partners opened 143 new positions and closed 137 in Q4 2024.
- Adage Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $57.2B.
Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.